Biblio
Export 1382 results:
Author Title [ Type
Filters: First Letter Of Last Name is G [Clear All Filters]
“Dual Kinase Inhibition Affords Extended in vitro Neuroprotection in Amyloid-β Toxicity.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1659-1670, 2016.
, “Dual Mechanism of Toxicity for Extracellular Injection of Tau Oligomers versus Monomers in Human Tau Mice.”, J Alzheimers Dis, vol. 59, no. 2, pp. 743-751, 2017.
, “Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1105-1116, 2018.
, “Dynamic PET imaging in patients with unilateral carotid occlusion shows lateralized cerebral hypoperfusion, but no amyloid binding.”, J Alzheimers Dis, p. 13872877251329593, 2025.
, “Dynamics of Frailty and Cognition After Age 50: Why It Matters that Cognitive Decline is Mostly Seen in Old Age.”, J Alzheimers Dis, vol. 58, no. 1, pp. 231-242, 2017.
, “Dysregulation of Autophagy, Mitophagy, and Apoptotic Genes in the Medial Temporal Lobe Cortex in an Ischemic Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 113-21, 2016.
, “Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 2, pp. 669-78, 2016.
, “Early Amnestic Mild Cognitive Impairment Is Associated with Reduced Total Cerebral Blood Flow with no Brain Tissue Loss.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1313-1322, 2023.
, “Early and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 237-249, 2018.
, “Early Astrocytic Dysfunction Is Associated with Mistuned Synapses as well as Anxiety and Depressive-Like Behavior in the AppNL-F Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 3, pp. 1017-1037, 2024.
, “Early Candidate Urine Biomarkers for Detecting Alzheimer's Disease Before Amyloid-β Plaque Deposition in an APP (swe)/PSEN1dE9 Transgenic Mouse Model.”, J Alzheimers Dis, vol. 66, no. 2, pp. 613-637, 2018.
, “Early Detection of Alzheimer's Disease Based on the Patient's Creative Drawing Process: First Results with a Novel Neuropsychological Testing Method.”, J Alzheimers Dis, vol. 63, no. 2, pp. 675-687, 2018.
, “Early Detection of Learning Difficulties when Confronted with Novel Information in Preclinical Alzheimer's Disease Stage 1.”, J Alzheimers Dis, vol. 58, no. 3, pp. 855-870, 2017.
, “Early Emotional Attention is Impacted in Alzheimer's Disease: An Eye-Tracking Study.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1445-1458, 2018.
, “Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition.”, J Alzheimers Dis, vol. 53, no. 2, pp. 547-56, 2016.
, “Early Stage Alterations in CA1 Extracellular Region Proteins Indicate Dysregulation of IL6 and Iron Homeostasis in the 5XFAD Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1399-1410, 2018.
, “EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 55, no. 1, pp. 53-58, 2017.
, “EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 55, no. 1, pp. 53-58, 2017.
, “EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 55, no. 1, pp. 53-58, 2017.
, “EEG Markers of Dementia with Lewy Bodies: A Multicenter Cohort Study.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1649-1657, 2016.
, “Effect of a Comprehensive Intervention on Plasma BDNF in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 1, pp. 37-43, 2017.
, “Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 63, no. 2, pp. 861-869, 2018.
, “The Effect of Exercise on Falls in People Living with Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 92, no. 4, pp. 1199-1217, 2023.
, “Effect of Fluvoxamine on Amyloid-β Peptide Generation and Memory.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1777-1787, 2018.
, “Effect of Metabolic Syndrome Risk Factors on Processing Speed and Executive Function in Three Racialized Groups.”, J Alzheimers Dis, vol. 92, no. 1, pp. 285-294, 2023.
,